These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

863 related items for PubMed ID: 26059526

  • 1. Predictive parameters of response to desmopressin in primary nocturnal enuresis.
    Van Herzeele C, Evans J, Eggert P, Lottmann H, Norgaard JP, Vande Walle J.
    J Pediatr Urol; 2015 Aug; 11(4):200.e1-8. PubMed ID: 26059526
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tailoring treatment of monosymptomatic nocturnal enuresis: the role of maximum voided capacity.
    Tauris LH, Kamperis K, Hagstroem S, Bower WF, Rittig S.
    J Urol; 2012 Feb; 187(2):664-9. PubMed ID: 22177206
    [Abstract] [Full Text] [Related]

  • 7. Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
    De Guchtenaere A, Vande Walle C, Van Sintjan P, Donckerwolcke R, Raes A, Dehoorne J, Van Laecke E, Hoebeke P, Vande Walle J.
    J Urol; 2007 Dec; 178(6):2635-9; discussion 2639. PubMed ID: 17945291
    [Abstract] [Full Text] [Related]

  • 8. Long-term desmopressin response in primary nocturnal enuresis: open-label, multinational study.
    Lottmann H, Baydala L, Eggert P, Klein BM, Evans J, Norgaard JP.
    Int J Clin Pract; 2009 Jan; 63(1):35-45. PubMed ID: 19125991
    [Abstract] [Full Text] [Related]

  • 9. Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.
    Berkenwald A, Pires J, Ellsworth P.
    J Pediatr Urol; 2016 Aug; 12(4):220.e1-6. PubMed ID: 27373215
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence of partial anti-enuretic response related to poor pharmacodynamic effects of desmopressin nasal spray.
    De Guchtenaere A, Raes A, Vande Walle C, Hoebeke P, Van Laecke E, Donckerwolcke R, Vande Walle J.
    J Urol; 2009 Jan; 181(1):302-9; discussion 309. PubMed ID: 19013601
    [Abstract] [Full Text] [Related]

  • 12. The effect of desmopressin on renal water and solute handling in desmopressin resistant monosymptomatic nocturnal enuresis.
    Kamperis K, Rittig S, Radvanska E, Jørgensen KA, Djurhuus JC.
    J Urol; 2008 Aug; 180(2):707-13; discussion 713-4. PubMed ID: 18554642
    [Abstract] [Full Text] [Related]

  • 13. Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis.
    Skoog SJ, Stokes A, Turner KL.
    J Urol; 1997 Sep; 158(3 Pt 2):1035-40. PubMed ID: 9258137
    [Abstract] [Full Text] [Related]

  • 14. Comparison of long-term efficacy of desmopressin lyophilisate and enuretic alarm for monosymptomatic enuresis and assessment of predictive factors for success: a randomized prospective trial.
    Önol FF, Guzel R, Tahra A, Kaya C, Boylu U.
    J Urol; 2015 Feb; 193(2):655-61. PubMed ID: 25158273
    [Abstract] [Full Text] [Related]

  • 15. Neuropsychological functioning related to specific characteristics of nocturnal enuresis.
    Van Herzeele C, Dhondt K, Roels SP, Raes A, Groen LA, Hoebeke P, Walle JV.
    J Pediatr Urol; 2015 Aug; 11(4):208.e1-6. PubMed ID: 26206411
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of oral desmopressin in children with primary nocturnal enuresis.
    Schulman SL, Stokes A, Salzman PM.
    J Urol; 2001 Dec; 166(6):2427-31. PubMed ID: 11696804
    [Abstract] [Full Text] [Related]

  • 17. Reboxetine in therapy-resistant enuresis: A randomized placebo-controlled study.
    Lundmark E, Stenberg A, Hägglöf B, Nevéus T.
    J Pediatr Urol; 2016 Dec; 12(6):397.e1-397.e5. PubMed ID: 27544904
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of Urinary Aquaporin 2 and Plasma Copeptin as Biomarkers of Effectiveness of Desmopressin Acetate for the Treatment of Monosymptomatic Nocturnal Enuresis.
    Hara T, Ohtomo Y, Endo A, Niijima S, Yasui M, Shimizu T.
    J Urol; 2017 Oct; 198(4):921-927. PubMed ID: 28457803
    [Abstract] [Full Text] [Related]

  • 19. Alarm interventions for nocturnal enuresis in children.
    Caldwell PH, Codarini M, Stewart F, Hahn D, Sureshkumar P.
    Cochrane Database Syst Rev; 2020 May 04; 5(5):CD002911. PubMed ID: 32364251
    [Abstract] [Full Text] [Related]

  • 20. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
    Radvanska E, Kovács L, Rittig S.
    J Urol; 2006 Aug 04; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.